Recent changes in the epidemiology of invasive mycosis;Modifications récentes de l'épidémiologie des mycoses invasives

Revue Francophone des Laboratoires

Volumn 37, Issue 396, 2007, Pages 85-89

  Gangneux, Jean Pierre ^a   Guiguen, Claude ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

Aspergillus; Candida; Cryptococcus; Invasive; Mycosis; Pneumocystis jiroveci

Indexed keywords

EID: 39049151258     PISSN: 1773035X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1773-035x(07)80367-4     Document Type: Review

References (24)

1. Abi-Said D., Anaissie E., Uzun O., Raad I., Pinzcowski H., Vartivarian S., The epidemiology of hematogenous candidiasis caused by different Candida species, Clin. Infect. Dis. 24 (1997) 1122-1128.
2. Baculard A., Les infections fongiques dans la mucoviscidose, J. Mycol. Med. 9 (1999) 24-29.
3. Bonassoli L.A., Bertoli M., Svidzinski T.I., High frequency of Candida parapsilosis on the hands of healthy hosts, J. Hosp. Infect. 59 (2005) 159-162.
4. Cornillet A., Camus C., Nimubona S., Gandemer V., Tattevin P., Belleguic C., Chevrier S., Meunier C., Faucheux M., Caulet-maugendre S., Lebert C., Aupée M., Lelong B., Guiguen C., Gangneux J.P., Comparison of epidemiological, clinical and biological features of invasive aspergillosis in neutropenic and non-neutropenic patients: a 6-year survey, Clin. Infect. Dis. 43 (2006) 577-584.
5. Dromer F., Mathoulin-Pelissier S., Launay O., Lortholary O. and the French Cryptococcosis study group, Determinants of disease presentation and outcome during Cryptococcosis: The CryptoA/D Study, PLoS Med. 4 (2007) e21.
6. Festic E., Gajic O., Limper A.H., Aksamit T.R., Acute respiratory failure due to Pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features, Chest 128 (2005) 573-579.
7. Garnacho-Montero J., Amaya-Villar R., Ortiz-Leyba C., Leon C., Alvarez-Lerma F., Nolla-Salas J., Iruretagoyena J.R., Barcenilla F., Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome, Crit. Care 9 (2005) R191-199.
8. Glockner A., Vehreschild J.J., Cornely O.A., Zygomycosis - current epidemiological aspects, Mycoses 50 Suppl 1 (2007) 50-55.
9. Krcmery V., Barnes A.J., Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance, J. Hosp. Infect. 50 (2002) 243-260.
10. Latge J.P., Aspergillus fumigatus and aspergillosis, Clin. Microbiol. Rev. 12 (1999) 310-350.
11. Magne D., Lacube P., Angoulvant A., Meliani L., Botterel F., Bougnoux M.E., Chochillon C., Cornet M., Dannaoui E., Datry A., Dunand J., Galeazzi G., Bouges-Michel C., Yera H., Sarfati C., Roux P., Pneumocystosis : survey and DHPS genotype analysis in 14 Parisian hospitals in 2003 and 2004, J. Eukaryot. Microbiol. 53 Suppl 1 (2006) S106-107.
12. Malani A.N., Kauffman C.A., Changing epidemiology of rare mould infections: implications for therapy, Drugs 67(2007) 1803-1812.
13. Marchetti O., Bille J., Fluckiger U., Eggimann P., Ruef C., Garbino J., Calandra T., Glauser M.P., Tauber M.G., Pittet D. and Fungal infection network of Switzerl. epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000, Clin. Infect. Dis. 38 (2004) 311-320.
14. Meersseman W., Vandecasteele S.J., Wilmer A., Verbeken E., Peetermans W.E., Van Wijngaerden E., Invasive aspergillosis in critically ill patients without malignancy, Am. J. Respir. Crit. Care Med. 170 (2004) 621-625.
15. Navin T.R., Beard C.B., Huang L., del Rio C., Lee S., Pieniazek N.J., Carter J.L., Le T., Hightower A., Rimland D., Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study, Lancet 358 (2001) :545-549.
16. Paterson D.L., New clinical presentations of invasive aspergillosis in non-conventional hosts, Clin. Microbiol. Infect. 10 Suppl 1 (2004) 24-30.
17. Ritz N., Ammann R.A., Casaulta Aebischer C., Schoeni-Affolter F., Schoeni M.H., Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis, Eur. J. Pediatr. 164 (2005) 577-582.
18. Sendid B., Lacroix C., Bougnoux M.E., Is Candida kefyr an emerging pathogen in patients with oncohematological diseases?, Clin. Infect. Dis. 43 (2006) 666-667.
19. Skov M., McKay K., Koch C., Cooper P.J., Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy, Respir. Med. 99 (2005) 887-893.
20. Stevens D.A., Moss R.B., Kurup V.P., Knutsen A.P., Greenberger P., Judson M.A., Denning D.W., Crameri R., Brody A.S., Light M., Skov M., Maish W., Mastella G., Participants in the Cystic fibrosis foundation consensus conference, Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic fibrosis foundation consensus conference, Clin. Infect. Dis. 37 Suppl 3 (2003) S225-S264.
21. Trifilio S.M., Bennett C.L., Yarnold P.R., McKoy J.M., Parada J., Mehta J., Chamilos G., Palella F., Kennedy L., Mullane K., Tallman M.S., Evens A., Scheetz M.H., Blum W., Kontoyiannis D.P., Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy, Bone Marrow. Transplant. 39 (2007) 425-429.
22. Upton A., Marr K.A., Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient, Curr. Infect. Dis. Rep. 8 (2006) 434-441.
23. Viudes A., Peman J., Canton E., Salavert M., Ubeda P., Lopez-Ribot J.L., Gobernado M., Two cases of fungemia due to Candida lusitaniae and a literature review, Eur. J. Clin. Microbiol. Infect. Dis. 21 (2002) 294-299.
24. Wingard J.R., Merz W.G., Rinaldi M.G., Johnson T.R., Karp J.E., Saral R., Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole, N. Engl. J. Med. 325 (1991) 1274-1277.